The human immune system has only recently begun to reveal many of its long hidden secrets which can potentially be exploited to turn it into an increasingly effective tool in the fight against cancer. Immune therapies have already demonstrated their ability to actually cure widely metastatic cancers for a select few patients.
The primary goal of the Immunotherapy Program at Penn State Hershey is to increase the number of patients completely and definitively cured by immunotherapy as well as expanding the pool of different tumors susceptible to this form of therapy. To this end, we are already engaged in the immunotherapy of malignancies in the clinic using conventional therapies which are outlined in Clinical Services. We are also involved in both basic and translational research to further unlock the power of the immune system as outlined in our Current Research.
It is our belief that using the appropriate immune therapies in the appropriate sequence to activate, expand and disinhibit the components of the human immune system, may actually lead to the cure of many different types of cancer.